Diebold Nixdorf (DBD): insider & executive buying
Diebold Nixdorf · Information Technology · ref. ETF XLK · price $67.68
In short — 3 insiders bought Diebold Nixdorf over ~6 months (4 buys, total $300k, latest Jul 31, 26) — cluster buy. Public Form 4 data, informative (not a performance signal).
Are Diebold Nixdorf's executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$67.68+8.5% over range
Aug 28, 25low $54.9 · high $90.75Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 1 analysts
Latest insider buys on Diebold Nixdorf
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| Jul 31, 26 | Timko Thomas S | EVP, CFO | 700 | $51k |
| May 26, 26 | Marquez Octavio | Pres, CEO | 1,250 | $99k |
| May 22, 26 | Timko Thomas S | EVP, CFO | 672 | $50k |
| May 22, 26 | Myers Jonathan | EVP, Chief Revenue Officer | 1,360 | $100k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Diebold Nixdorf's executives bought shares recently?
3 Diebold Nixdorf insider(s) bought $300k over ~6 months (latest Jul 31, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for DBD?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Diebold Nixdorf? The JPI assistant answers using our backtest data.
Keep exploring Diebold Nixdorf